Stock Analysis

Else Nutrition Holdings (CVE:BABY) one-year losses have grown faster than shareholder returns have fallen, but the stock surges 22% this past week

  •  Updated
Source: Shutterstock

It's nice to see the Else Nutrition Holdings Inc. (CVE:BABY) share price up 22% in a week. But that is minimal compensation for the share price under-performance over the last year. In fact, the price has declined 49% in a year, falling short of the returns you could get by investing in an index fund.

The recent uptick of 22% could be a positive sign of things to come, so let's take a lot at historical fundamentals.

Check out our latest analysis for Else Nutrition Holdings

Else Nutrition Holdings wasn't profitable in the last twelve months, it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option. Shareholders of unprofitable companies usually expect strong revenue growth. That's because it's hard to be confident a company will be sustainable if revenue growth is negligible, and it never makes a profit.

In the last year Else Nutrition Holdings saw its revenue grow by 213%. That's well above most other pre-profit companies. Given the revenue growth, the share price drop of 49% seems quite harsh. Our sympathies to shareholders who are now underwater. Prima facie, revenue growth like that should be a good thing, so it's worth checking whether losses have stabilized. Our brains have evolved to think in linear fashion, so there's value in learning to recognize exponential growth. We are, in some ways, simply the wisest of the monkeys.

You can see below how earnings and revenue have changed over time (discover the exact values by clicking on the image).

TSXV:BABY Earnings and Revenue Growth November 24th 2021

Balance sheet strength is crucial. It might be well worthwhile taking a look at our free report on how its financial position has changed over time.

A Different Perspective

While Else Nutrition Holdings shareholders are down 49% for the year, the market itself is up 28%. While the aim is to do better than that, it's worth recalling that even great long-term investments sometimes underperform for a year or more. With the stock down 33% over the last three months, the market doesn't seem to believe that the company has solved all its problems. Given the relatively short history of this stock, we'd remain pretty wary until we see some strong business performance. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. To that end, you should learn about the 4 warning signs we've spotted with Else Nutrition Holdings (including 1 which is significant) .

We will like Else Nutrition Holdings better if we see some big insider buys. While we wait, check out this free list of growing companies with considerable, recent, insider buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on CA exchanges.

Valuation is complex, but we're helping make it simple.

Find out whether Else Nutrition Holdings is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis